Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,332 total articles
Agencia Comercial Spirits Ltd, listed on NASDAQ, announced that its subsidiary has entered into a five-year technical services agreement worth $10 million with a regional provider to support networking integration for its AI computing infrastructure deployment in Indonesia. This initiative is a co-primary business alongside its established premium …
Tvardi Therapeutics, a clinical-stage biopharmaceutical company listed on NASDAQ under the ticker TVRD, will host a webinar featuring Dr. Randy Longman to discuss the evolving treatment landscape of ulcerative colitis (UC) and new data on their investigational oral small molecule drug TTI-109 targeting STAT3. The Phase 1 healthy volunteer results s…
Binah Capital Group, a NASDAQ-listed financial services company, announced its participation in the Sidoti Micro-Cap Virtual Conference scheduled for August 19-20, 2026. The company's CEO and CFO will present on August 20, sharing insights into Binah's hybrid-friendly platform that supports independent financial advisors (RIAs). The event webcast w…
Antalpha Platform Holding Company, a Nasdaq-listed fintech firm specializing in digital asset financing for the Web3 industry, announced it will release its Q2 2026 financial results on August 19, 2026, prior to the market open. The management team will host a conference call to discuss the results and address investor questions.
Teck Resources Limited obtained majority consents from holders of its outstanding notes to approve proposed amendments aligning debt covenants with those of Anglo American plc in anticipation of an expected merger. The consent solicitations have expired, amendments have been executed, and consent fees will be paid. The merger between Teck and Anglo…
Nexera Technologies' majority-owned subsidiary, Fort Technology Inc., has signed agreements to acquire a 50.1% stake in Logia USA, a company focused on advanced fuel integrity solutions for data centers and mission-critical facilities in the U.S. The acquisition involves issuing shares valued at $125,000 and providing a $2 million credit facility t…
3 E Network Technology Group Limited announced the completion of the initial system-level architecture specification for its next-generation customized AI storage controller and preliminary validation of its core data flow algorithms through software simulation. This progress marks a key step in the development of hardware designed to overcome Inpu…
Ming Shing Group Holdings Limited (NASDAQ: PMA), a Hong Kong-based company focused on wet trades works and graphene technology, announced entering into a stock purchase agreement to acquire Meals Through Seasons Limited, a company controlling MTHK which operates in organic agricultural supply chain, cold chain logistics, and product processing. The…
BrainsWay Ltd. reported a strong second quarter 2026 with revenue increasing 35% year-over-year to $17.1 million, a more than doubling of adjusted EBITDA to $3.5 million, and record shipments of Deep TMS systems up 42%. The company raised its full-year 2026 revenue guidance to $68-$70 million and adjusted EBITDA to $13-$14 million, citing expanding…
PolyPid Ltd. reports FDA acceptance with Priority Review for its NDA submission of D-PLEX100 aimed at preventing surgical site infections in abdominal colorectal surgeries. The FDA PDUFA goal date is set for November 28, 2026, ahead of prior guidance, with a potential commercial launch in early 2027 under an exclusive U.S. and Canada partnership wi…
Rekor Systems announced that their GoSecure platform now includes patent-pending audio verification capabilities, applying cryptographic authentication to audio recordings. This extends their technology beyond video to meet growing demands from law enforcement, courts, financial institutions, and government agencies for verifiable and tamper-proof …
Altimmune, Inc. announced key advancements in its late-stage clinical program for pemvidutide, targeting metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company initiated a global Phase 3 PERFORMA trial in MASH, reported positive Phase 2 topline data in AUD, and co…
Arbutus Biopharma reported a solid financial position at the end of Q2 2026, including receipt of a $178 million settlement payment from Moderna. The company filed international patent enforcement lawsuits against Pfizer and BioNTech related to its lipid nanoparticle technology. It also obtained FDA Fast Track designation for imdusiran, its hepatit…
Nexxen announced key executive appointments including Chance Johnson as President, Kara Puccinelli as Chief Commercial Officer, and Kenneth Suh as Chief Business Officer to strengthen leadership as the company scales its AI-powered unified advertising platform. These appointments aim to enhance strategic client relationships, expand enterprise grow…
Nexxen International Ltd. reported record second quarter 2026 financial results, with Contribution ex-TAC of $97.8 million and programmatic revenue of $95.2 million, reflecting double-digit year-over-year growth. The company achieved an all-time record for quarterly Connected TV (CTV) revenue, up 33% year-over-year. Nexxen advanced its AI technolog…
Xilio Therapeutics announced FDA clearance of its IND application for XTX501, a bispecific PD-1/masked IL-2 therapy targeting solid tumors. The company is advancing additional masked T cell engager programs with anticipated IND submissions in 2027. Q2 financials showed increased collaboration revenue and reduced net loss, with a strong cash runway …
Adagene Inc. announced its financial results for the six months ended June 30, 2026, highlighting significant clinical advancements in its lead candidate muzastotug (ADG126), a masked anti-CTLA-4 antibody. The company reported encouraging efficacy and safety data in microsatellite stable colorectal cancer (MSS CRC) and hepatocellular carcinoma (HCC…
Unicycive Therapeutics announced its Q2 2026 financial results and provided a business update highlighting progress toward FDA approval of its lead drug candidate, oxylanthanum carbonate (OLC), for treating hyperphosphatemia in dialysis patients. The FDA has assigned a facility inspection to the third-party manufacturer, a prerequisite for NDA resu…
Polar Power, Inc. announced $7.9 million in revenue from the Pacific Islands since 2024, driven by 333 shipments of DC power and solar-hybrid systems to countries including Papua New Guinea and Fiji. Repeat orders from telecommunications customers indicate growing adoption and reliability of its technology. The company is now expanding into adjacen…
Electra Battery Materials Corporation announced the appointment of Peter Rawlins as its new CFO, effective August 26, 2026, bringing extensive mining finance and capital markets experience. The company reported Q2 2026 financial results showing progress in the construction of North America's first cobalt sulfate refinery in Ontario, with constructi…
Milestone Pharmaceuticals announced Q2 2026 financial results and corporate updates, reporting increased patient and prescriber adoption of its FDA-approved cardiovascular drug CARDAMYST for PSVT, expanded insurance coverage to over 50% of commercially insured lives in the U.S., and initiation of a Phase 3 registrational trial for atrial fibrillati…
Alterity Therapeutics announced the granting of a new U.S. composition of matter patent for its lead clinical drug candidate ATH434. This patent extends protection until at least 2045, significantly increasing ATH434's commercial value and underpinning the planned initiation of Phase 3 trials in Multiple System Atrophy by the end of 2026. The stren…
Kamada Ltd., a global biopharmaceutical company specializing in specialty plasma-derived therapies, announced record-high revenues and adjusted EBITDA for the first half and second quarter of 2026, driven by strong sales growth of its proprietary products like KEDRAB in the U.S., VARIZIG, and HEPAGAM. The company affirmed its 2026 annual financial …
TScan Therapeutics reported second quarter 2026 financial results and corporate updates highlighting the dosing of the first patient in the Phase 3 ALLOHA-2 study evaluating their lead TCR-T therapy candidate TSC-101. Positive initial data from the Phase 1 ALLOHA study validated their commercial-ready manufacturing process. The company has a health…
Perma-Fix Environmental Services, Inc. has been awarded a Master IDIQ subcontract by Hanford Tank Waste Operations & Closure, LLC for the treatment and disposal of pretreated liquid mixed low-level waste from the DOE's Hanford Site. The subcontract is effective from August 2026 with task orders expected to begin in 2027, running through 2041. The w…
